Association Between SPOP Gene Mutations and Response to Androgen Therapy - Neeraj Agarwal & Daniel Petrylak
Association Between SPOP Gene Mutations and Response to Andro…
3 months ago
urotoday.com
Discussion on Patient Selection for Radioligand Therapy in Prostate Cancer - Oliver Sartor and Daniel Petrylak
Discussion on Patient Selection for Radioligand Therapy in Prostate C…
3 months ago
urotoday.com
Dr. Petrylak on Imaging Approaches in Prostate Cancer
Dr. Petrylak on Imaging Approaches in Prostate Cancer
Apr 25, 2014
onclive.com
Dr. Petrylak on Chemotherapy in Prostate Cancer
Dr. Petrylak on Chemotherapy in Prostate Cancer
Apr 11, 2012
onclive.com
Dr. Petrylak on Atezolizumab in Bladder Cancer | OncLive
Dr. Petrylak on Atezolizumab in Bladder Cancer | OncLive
Dec 15, 2015
onclive.com
Dr. Petrylak on Immunotherapy in Bladder Cancer | OncLive
Dr. Petrylak on Immunotherapy in Bladder Cancer | OncLive
Mar 28, 2016
onclive.com
Dr. Petrylak on Future Research in Prostate Cancer | OncLive
Dr. Petrylak on Future Research in Prostate Cancer | OncLive
2 weeks ago
onclive.com
Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties
Mar 28, 2011
onclive.com
Dr. Petrylak on Novel Immunotherapy Research in Blad…
Jan 4, 2017
onclive.com
Dr. Petrylak on Custirsen in Prostate Cancer
Mar 24, 2014
onclive.com
Dr. Petrylak on the Future Immunotherapy in Bladder Cancer
May 27, 2015
onclive.com
Dr. Petrylak on Trial of Atezolizumab in Urothelial Carcinoma | OncLive
2 months ago
onclive.com
Dr. Petrylak on the Role of Docetaxel in mHSPC
Dec 2, 2020
onclive.com
Dr. Petrylak on Novel Imaging Modalities in Prostate Cancer | On…
6 days ago
onclive.com
Dr. Petrylak on FDA Approval of Nivolumab in Bladder Cancer
Feb 3, 2017
onclive.com
Dr. Petrylak on Sequencing of Targeted Agents in Bladder Cance…
Jan 20, 2017
onclive.com
Dr. Petrylak on FDA Approval of Pembrolizumab in Bladder Cance…
1 week ago
onclive.com
Dr. Petrylak on Available Treatment Options in Metastatic Bladder Can…
Mar 13, 2020
onclive.com
Dr. Petrylak on Immunotherapy for Second-line Treatment in Bladder …
Mar 14, 2015
onclive.com
Dr. Petrylak on Ongoing Investigations of Checkpoint Inhib…
Jan 31, 2017
onclive.com
Dr. Petrylak on Pivotal PARP Inhibitor Trials in mCRPC With DN…
Sep 28, 2020
onclive.com
Dr Petrylak on Treatment With Enfortumab Vedotin/Pembrolizum…
Apr 4, 2024
onclive.com
Dr. Petrylak on the Results of the Phase II STRIDE Study | OncLive
1 week ago
onclive.com
Dr Petrylak on the Potential Use of Erdafitinib in Metastatic Urothelial …
Sep 15, 2023
onclive.com
Dr. Petrylak on Enzalutamide's Role in Prostate Cancer | OncLive
Oct 9, 2012
onclive.com
Dr. Petrylak on the Rationale of the EV-103 Trial in MIBC
Mar 14, 2022
onclive.com
Dr. Petrylak on Enfortumab Vedotin in Locally Advanced or Metastatic …
Jun 4, 2019
onclive.com
Dr Petrylak on the Importance of Early Detection to Minimize Treat…
7 months ago
onclive.com
1:20
230K views · 4.9K reactions | cómo integramos tres soluciones premi…
141K views1 week ago
FacebookDaniel Carpintex
42:40
403K views · 16K reactions | El Rey David. Capítulo 7. La vida de...
403.4K views1 week ago
FacebookDaniel Prieto
See more videos
Static thumbnail place holder